Akeso lung cancer drug shines in trials, boosting hopes in US$20b market
AdvertisementChina’s private sectorBusinessChina Business Akeso lung cancer drug shines in trials, boosting hopes in US$20b market Ivonescimab phase three trials…
China’s drug regulator clears wave of home-grown innovative medicines amid biotech boom
AdvertisementChina’s private sectorBusinessChina Business China’s drug regulator clears wave of home-grown innovative medicines amid biotech boom Domestic firms dominate China’s…